Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 2761 to 2772 of 2788 entries
Sorted by: Best Match Show Resources per page
CRISPR Cas System: An efficient tool for cancer modelling.

JPMA. The Journal of the Pakistan Medical Association

Akhtar M, Jamal T, Khan M, Khan SR, Haider S, Jalil F.
PMID: 33941966
J Pak Med Assoc. 2021 Feb;71(2):718-724. doi: 10.47391/JPMA.801.

The Clustered Regularly Interspaced Short Palindromic Repeats-Cas-9 (CRISPR-Cas9) system has been a revolutionising tool in the field of molecular genetics, which provides a versatile range of editing potentials. Researchers can produce breaks or alter genomes with ease using the...

Cite
Akhtar M, Jamal T, Khan M, et al. CRISPR Cas System: An efficient tool for cancer modelling. J Pak Med Assoc. 2021;71(2):718-724doi: 10.47391/JPMA.801.
Akhtar, M., Jamal, T., Khan, M., Khan, S. R., Haider, S., & Jalil, F. (2021). CRISPR Cas System: An efficient tool for cancer modelling. JPMA. The Journal of the Pakistan Medical Association, 71(2), 718-724. https://doi.org/10.47391/JPMA.801
Akhtar, Mehran, et al. "CRISPR Cas System: An efficient tool for cancer modelling." JPMA. The Journal of the Pakistan Medical Association vol. 71,2 (2021): 718-724. doi: https://doi.org/10.47391/JPMA.801
Akhtar M, Jamal T, Khan M, Khan SR, Haider S, Jalil F. CRISPR Cas System: An efficient tool for cancer modelling. J Pak Med Assoc. 2021 Feb;71(2):718-724. doi: 10.47391/JPMA.801. PMID: 33941966.
Copy Download .nbib Format: NLM
Open-source Software Sustainability Models: Initial White Paper From the Informatics Technology for Cancer Research Sustainability and Industry Partnership Working Group.

Journal of medical Internet research

Ye Y, Barapatre S, Davis MK, Elliston KO, Davatzikos C, Fedorov A, Fillion-Robin JC, Foster I, Gilbertson JR, Lasso A, Miller JV, Morgan M, Pieper S, Raumann BE, Sarachan BD, Savova G, Silverstein JC, Taylor DP, Zelnis JB, Zhang GQ, Cuticchia J, Becich MJ.
PMID: 34860667
J Med Internet Res. 2021 Dec 02;23(12):e20028. doi: 10.2196/20028.

BACKGROUND: The National Cancer Institute Informatics Technology for Cancer Research (ITCR) program provides a series of funding mechanisms to create an ecosystem of open-source software (OSS) that serves the needs of cancer research. As the ITCR ecosystem substantially grows,...

Cite
Ye Y, Barapatre S, Davis MK, et al. Open-source Software Sustainability Models: Initial White Paper From the Informatics Technology for Cancer Research Sustainability and Industry Partnership Working Group. J Med Internet Res. 2021;23(12):e20028doi: 10.2196/20028.
Ye, Y., Barapatre, S., Davis, M. K., Elliston, K. O., Davatzikos, C., Fedorov, A., Fillion-Robin, J. C., Foster, I., Gilbertson, J. R., Lasso, A., Miller, J. V., Morgan, M., Pieper, S., Raumann, B. E., Sarachan, B. D., Savova, G., Silverstein, J. C., Taylor, D. P., Zelnis, J. B., Zhang, G. Q., Cuticchia, J., & Becich, M. J. (2021). Open-source Software Sustainability Models: Initial White Paper From the Informatics Technology for Cancer Research Sustainability and Industry Partnership Working Group. Journal of medical Internet research, 23(12), e20028. https://doi.org/10.2196/20028
Ye, Ye, et al. "Open-source Software Sustainability Models: Initial White Paper From the Informatics Technology for Cancer Research Sustainability and Industry Partnership Working Group." Journal of medical Internet research vol. 23,12 (2021): e20028. doi: https://doi.org/10.2196/20028
Ye Y, Barapatre S, Davis MK, Elliston KO, Davatzikos C, Fedorov A, Fillion-Robin JC, Foster I, Gilbertson JR, Lasso A, Miller JV, Morgan M, Pieper S, Raumann BE, Sarachan BD, Savova G, Silverstein JC, Taylor DP, Zelnis JB, Zhang GQ, Cuticchia J, Becich MJ. Open-source Software Sustainability Models: Initial White Paper From the Informatics Technology for Cancer Research Sustainability and Industry Partnership Working Group. J Med Internet Res. 2021 Dec 02;23(12):e20028. doi: 10.2196/20028. PMID: 34860667.
Copy Download .nbib Format: NLM
Integrative cancer genomics in the era of precision cancer medicine.

Journal of human genetics

Inazawa J, Miki Y, Nakamura Y.
PMID: 34429508
J Hum Genet. 2021 Sep;66(9):843. doi: 10.1038/s10038-021-00970-6. Epub 2021 Aug 16.

No abstract available.

Cite
Inazawa J, Miki Y, Nakamura Y. Integrative cancer genomics in the era of precision cancer medicine. J Hum Genet. 2021;66(9):843doi: 10.1038/s10038-021-00970-6.
Inazawa, J., Miki, Y., & Nakamura, Y. (2021). Integrative cancer genomics in the era of precision cancer medicine. Journal of human genetics, 66(9), 843. https://doi.org/10.1038/s10038-021-00970-6
Inazawa, Johji, et al. "Integrative cancer genomics in the era of precision cancer medicine." Journal of human genetics vol. 66,9 (2021): 843. doi: https://doi.org/10.1038/s10038-021-00970-6
Inazawa J, Miki Y, Nakamura Y. Integrative cancer genomics in the era of precision cancer medicine. J Hum Genet. 2021 Sep;66(9):843. doi: 10.1038/s10038-021-00970-6. Epub 2021 Aug 16. PMID: 34429508.
Copy Download .nbib Format: NLM
[Local treatment other than surgery for small size malignancy].

Nihon Geka Gakkai zasshi

Kawamura M.
PMID: 21941825
Nihon Geka Gakkai Zasshi. 2011 Sep;112(5):337.

No abstract available.

Cite
Kawamura M. [Local treatment other than surgery for small size malignancy]. Nihon Geka Gakkai Zasshi. 2011;112(5):337
Kawamura, M. (2011). [Local treatment other than surgery for small size malignancy]. Nihon Geka Gakkai zasshi, 112(5), 337.
Kawamura, Masafumi. "[Local treatment other than surgery for small size malignancy]." Nihon Geka Gakkai zasshi vol. 112,5 (2011): 337.
Kawamura M. [Local treatment other than surgery for small size malignancy]. Nihon Geka Gakkai Zasshi. 2011 Sep;112(5):337. Japanese. PMID: 21941825.
Copy Download .nbib Format: NLM
Advancing to the era of cancer immunotherapy.

Cancer communications (London, England)

Wang Y, Wang M, Wu HX, Xu RH.
PMID: 34165252
Cancer Commun (Lond). 2021 Sep;41(9):803-829. doi: 10.1002/cac2.12178. Epub 2021 Jun 24.

Cancer greatly affects the quality of life of humans worldwide and the number of patients suffering from it is continuously increasing. Over the last century, numerous treatments have been developed to improve the survival of cancer patients but substantial...

Cite
Wang Y, Wang M, Wu HX, et al. Advancing to the era of cancer immunotherapy. Cancer Commun (Lond). 2021;41(9):803-829doi: 10.1002/cac2.12178.
Wang, Y., Wang, M., Wu, H. X., & Xu, R. H. (2021). Advancing to the era of cancer immunotherapy. Cancer communications (London, England), 41(9), 803-829. https://doi.org/10.1002/cac2.12178
Wang, Yun, et al. "Advancing to the era of cancer immunotherapy." Cancer communications (London, England) vol. 41,9 (2021): 803-829. doi: https://doi.org/10.1002/cac2.12178
Wang Y, Wang M, Wu HX, Xu RH. Advancing to the era of cancer immunotherapy. Cancer Commun (Lond). 2021 Sep;41(9):803-829. doi: 10.1002/cac2.12178. Epub 2021 Jun 24. PMID: 34165252; PMCID: PMC8441060.
Copy Download .nbib Format: NLM
Prognostic factors at admission on patients with cancer and COVID-19: Analysis of HOPE registry data.

Medicina clinica

Pérez-Segura P, Paz-Cabezas M, Núñez-Gil IJ, Arroyo-Espliguero R, Maroun Eid C, Romero R, Fernández Rozas I, Uribarri A, Becerra-Muñoz VM, García Aguado M, Huang J, Rondano E, Cerrato E, Rodríguez EA, Ortega-Armas ME, Raposeiras Roubin S, Pepe M, Feltes G, Gonzalez A, Cortese B, Buzón L, El-Battrawy I, Estrada V.
PMID: 34154809
Med Clin (Barc). 2021 Oct 08;157(7):318-324. doi: 10.1016/j.medcli.2021.02.021. Epub 2021 May 06.

BACKGROUND: Previous works seem to agree in the higher mortality of cancer patients with COVID-19. Identifying potential prognostic factors upon admission could help identify patients with a poor prognosis.METHODS: We aimed to explore the characteristics and evolution of COVID-19...

Cite
Pérez-Segura P, Paz-Cabezas M, Núñez-Gil IJ, et al. Prognostic factors at admission on patients with cancer and COVID-19: Analysis of HOPE registry data. Med Clin (Barc). 2021;157(7):318-324doi: 10.1016/j.medcli.2021.02.021.
Pérez-Segura, P., Paz-Cabezas, M., Núñez-Gil, I. J., Arroyo-Espliguero, R., Maroun Eid, C., Romero, R., Fernández Rozas, I., Uribarri, A., Becerra-Muñoz, V. M., García Aguado, M., Huang, J., Rondano, E., Cerrato, E., Rodríguez, E. A., Ortega-Armas, M. E., Raposeiras Roubin, S., Pepe, M., Feltes, G., Gonzalez, A., Cortese, B., Buzón, L., El-Battrawy, I., & Estrada, V. (2021). Prognostic factors at admission on patients with cancer and COVID-19: Analysis of HOPE registry data. Medicina clinica, 157(7), 318-324. https://doi.org/10.1016/j.medcli.2021.02.021
Pérez-Segura, Pedro, et al. "Prognostic factors at admission on patients with cancer and COVID-19: Analysis of HOPE registry data." Medicina clinica vol. 157,7 (2021): 318-324. doi: https://doi.org/10.1016/j.medcli.2021.02.021
Pérez-Segura P, Paz-Cabezas M, Núñez-Gil IJ, Arroyo-Espliguero R, Maroun Eid C, Romero R, Fernández Rozas I, Uribarri A, Becerra-Muñoz VM, García Aguado M, Huang J, Rondano E, Cerrato E, Rodríguez EA, Ortega-Armas ME, Raposeiras Roubin S, Pepe M, Feltes G, Gonzalez A, Cortese B, Buzón L, El-Battrawy I, Estrada V. Prognostic factors at admission on patients with cancer and COVID-19: Analysis of HOPE registry data. Med Clin (Barc). 2021 Oct 08;157(7):318-324. doi: 10.1016/j.medcli.2021.02.021. Epub 2021 May 06. Spanish. PMID: 34154809; PMCID: PMC8101784.
Copy Download .nbib Format: NLM
Feasibility and Acceptability of a Mobile Phone App Intervention for Coping With Cancer as a Young Adult: Pilot Trial and Thematic Analysis.

Journal of medical Internet research

Poort H, Ryan A, MacDougall K, Malinowski P, MacDonald A, Markin Z, Pirl W, Greer J, Fasciano K.
PMID: 34114957
J Med Internet Res. 2021 Jun 11;23(6):e25069. doi: 10.2196/25069.

BACKGROUND: Many young adult patients do not receive adequate psychosocial services to help them cope with cancer.OBJECTIVE: This study aims to assess the feasibility and acceptability of a smartphone app (iaya) intervention that was designed to create an engaged...

Cite
Poort H, Ryan A, MacDougall K, et al. Feasibility and Acceptability of a Mobile Phone App Intervention for Coping With Cancer as a Young Adult: Pilot Trial and Thematic Analysis. J Med Internet Res. 2021;23(6):e25069doi: 10.2196/25069.
Poort, H., Ryan, A., MacDougall, K., Malinowski, P., MacDonald, A., Markin, Z., Pirl, W., Greer, J., & Fasciano, K. (2021). Feasibility and Acceptability of a Mobile Phone App Intervention for Coping With Cancer as a Young Adult: Pilot Trial and Thematic Analysis. Journal of medical Internet research, 23(6), e25069. https://doi.org/10.2196/25069
Poort, Hanneke, et al. "Feasibility and Acceptability of a Mobile Phone App Intervention for Coping With Cancer as a Young Adult: Pilot Trial and Thematic Analysis." Journal of medical Internet research vol. 23,6 (2021): e25069. doi: https://doi.org/10.2196/25069
Poort H, Ryan A, MacDougall K, Malinowski P, MacDonald A, Markin Z, Pirl W, Greer J, Fasciano K. Feasibility and Acceptability of a Mobile Phone App Intervention for Coping With Cancer as a Young Adult: Pilot Trial and Thematic Analysis. J Med Internet Res. 2021 Jun 11;23(6):e25069. doi: 10.2196/25069. PMID: 34114957; PMCID: PMC8235294.
Copy Download .nbib Format: NLM
[Well-being center in CHU of Liege : interest for oncological patients and their families].

Revue medicale de Liege

Paye A, Faymonville ME, Devos M.
PMID: 34080398
Rev Med Liege. 2021 May;76(5):559-564.

Although conventional medicine has made considerable progress in the treatment of cancer, this disease remains a distressing experience for patients who may feel they are losing control of their live. In response to this need for autonomy over their...

Cite
Paye A, Faymonville ME, Devos M. Centre de bien-être au CHU de Liège : intérêt pour les patients oncologiques et leurs proches. [Well-being center in CHU of Liege : interest for oncological patients and their families]. Rev Med Liege. 2021;76(5):559-564
Paye, A., Faymonville, M. E., & Devos, M. (2021). Centre de bien-être au CHU de Liège : intérêt pour les patients oncologiques et leurs proches. [Well-being center in CHU of Liege : interest for oncological patients and their families]. Revue medicale de Liege, 76(5), 559-564.
Paye, A, et al. "Centre de bien-être au CHU de Liège : intérêt pour les patients oncologiques et leurs proches." [Well-being center in CHU of Liege : interest for oncological patients and their families]. Revue medicale de Liege vol. 76,5 (2021): 559-564.
Paye A, Faymonville ME, Devos M. Centre de bien-être au CHU de Liège : intérêt pour les patients oncologiques et leurs proches. [Well-being center in CHU of Liege : interest for oncological patients and their families]. Rev Med Liege. 2021 May;76(5):559-564. French. PMID: 34080398.
Copy Download .nbib Format: NLM
Are we sufficiently aware of the complexity of systems and the need for a systemic approach to evaluating quality?.

Quality in primary care

Rotar Pavlic D.
PMID: 19416600
Qual Prim Care. 2009;17(2):93-4.

No abstract available.

Cite
Rotar Pavlic D. Are we sufficiently aware of the complexity of systems and the need for a systemic approach to evaluating quality?. Qual Prim Care. 2009;17(2):93-4
Rotar Pavlic, D. (2009). Are we sufficiently aware of the complexity of systems and the need for a systemic approach to evaluating quality?. Quality in primary care, 17(2), 93-4.
Rotar Pavlic, Danica. "Are we sufficiently aware of the complexity of systems and the need for a systemic approach to evaluating quality?." Quality in primary care vol. 17,2 (2009): 93-4.
Rotar Pavlic D. Are we sufficiently aware of the complexity of systems and the need for a systemic approach to evaluating quality?. Qual Prim Care. 2009;17(2):93-4. PMID: 19416600.
Copy Download .nbib Format: NLM
Support for families at home during childhood cancer treatment: a pilot study with Mr.V the Spaceman, a family-based activities tool.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

van Bindsbergen KLA, D'Olivo P, Rozendaal MC, Merks JHM, Grootenhuis MA.
PMID: 33550470
Support Care Cancer. 2021 Aug;29(8):4875-4884. doi: 10.1007/s00520-021-05995-3. Epub 2021 Feb 07.

PURPOSE: It is important to support families in dealing with the distress that comes along with the diagnosis and treatment of childhood cancer. Therefore, we developed a playful tool that families can use at home to support their family...

Cite
van Bindsbergen KLA, D'Olivo P, Rozendaal MC, et al. Support for families at home during childhood cancer treatment: a pilot study with Mr.V the Spaceman, a family-based activities tool. Support Care Cancer. 2021;29(8):4875-4884doi: 10.1007/s00520-021-05995-3.
van Bindsbergen, K. L. A., D'Olivo, P., Rozendaal, M. C., Merks, J. H. M., & Grootenhuis, M. A. (2021). Support for families at home during childhood cancer treatment: a pilot study with Mr.V the Spaceman, a family-based activities tool. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 29(8), 4875-4884. https://doi.org/10.1007/s00520-021-05995-3
van Bindsbergen, Kelly L A, et al. "Support for families at home during childhood cancer treatment: a pilot study with Mr.V the Spaceman, a family-based activities tool." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer vol. 29,8 (2021): 4875-4884. doi: https://doi.org/10.1007/s00520-021-05995-3
van Bindsbergen KLA, D'Olivo P, Rozendaal MC, Merks JHM, Grootenhuis MA. Support for families at home during childhood cancer treatment: a pilot study with Mr.V the Spaceman, a family-based activities tool. Support Care Cancer. 2021 Aug;29(8):4875-4884. doi: 10.1007/s00520-021-05995-3. Epub 2021 Feb 07. PMID: 33550470; PMCID: PMC8236466.
Copy Download .nbib Format: NLM
Racial/Ethnic differences in the health-related quality of life of cancer patients.

Journal of pain and symptom management

Rao D, Debb S, Blitz D, Choi SW, Cella D.
PMID: 18504096
J Pain Symptom Manage. 2008 Nov;36(5):488-96. doi: 10.1016/j.jpainsymman.2007.11.012. Epub 2008 May 27.

Previous research has suggested that, when compared to European Americans (EAs), African Americans (AAs) are at higher risk of metastatic disease at time of cancer diagnosis, and a higher risk of shorter survival. Although AA patients have reported worse...

Cite
Rao D, Debb S, Blitz D, et al. Racial/Ethnic differences in the health-related quality of life of cancer patients. J Pain Symptom Manage. 2008;36(5):488-96doi: 10.1016/j.jpainsymman.2007.11.012.
Rao, D., Debb, S., Blitz, D., Choi, S. W., & Cella, D. (2008). Racial/Ethnic differences in the health-related quality of life of cancer patients. Journal of pain and symptom management, 36(5), 488-96. https://doi.org/10.1016/j.jpainsymman.2007.11.012
Rao, Deepa, et al. "Racial/Ethnic differences in the health-related quality of life of cancer patients." Journal of pain and symptom management vol. 36,5 (2008): 488-96. doi: https://doi.org/10.1016/j.jpainsymman.2007.11.012
Rao D, Debb S, Blitz D, Choi SW, Cella D. Racial/Ethnic differences in the health-related quality of life of cancer patients. J Pain Symptom Manage. 2008 Nov;36(5):488-96. doi: 10.1016/j.jpainsymman.2007.11.012. Epub 2008 May 27. PMID: 18504096; PMCID: PMC2596636.
Copy Download .nbib Format: NLM
Automated Electronic Health Record-Based Tool for Identification of Patients With Metastatic Disease to Facilitate Clinical Trial Patient Ascertainment.

JCO clinical cancer informatics

Kirshner J, Cohn K, Dunder S, Donahue K, Richey M, Larson P, Sutton L, Siu E, Donegan J, Chen Z, Nightingale C, Estévez M, Hamrick HJ.
PMID: 34197178
JCO Clin Cancer Inform. 2021 Jun;5:719-727. doi: 10.1200/CCI.20.00180.

PURPOSE: To facilitate identification of clinical trial participation candidates, we developed a machine learning tool that automates the determination of a patient's metastatic status, on the basis of unstructured electronic health record (EHR) data.METHODS: This tool scans EHR documents,...

Cite
Kirshner J, Cohn K, Dunder S, et al. Automated Electronic Health Record-Based Tool for Identification of Patients With Metastatic Disease to Facilitate Clinical Trial Patient Ascertainment. JCO Clin Cancer Inform. 2021;5:719-727doi: 10.1200/CCI.20.00180.
Kirshner, J., Cohn, K., Dunder, S., Donahue, K., Richey, M., Larson, P., Sutton, L., Siu, E., Donegan, J., Chen, Z., Nightingale, C., Estévez, M., & Hamrick, H. J. (2021). Automated Electronic Health Record-Based Tool for Identification of Patients With Metastatic Disease to Facilitate Clinical Trial Patient Ascertainment. JCO clinical cancer informatics, 5719-727. https://doi.org/10.1200/CCI.20.00180
Kirshner, Jeffrey, et al. "Automated Electronic Health Record-Based Tool for Identification of Patients With Metastatic Disease to Facilitate Clinical Trial Patient Ascertainment." JCO clinical cancer informatics vol. 5 (2021): 719-727. doi: https://doi.org/10.1200/CCI.20.00180
Kirshner J, Cohn K, Dunder S, Donahue K, Richey M, Larson P, Sutton L, Siu E, Donegan J, Chen Z, Nightingale C, Estévez M, Hamrick HJ. Automated Electronic Health Record-Based Tool for Identification of Patients With Metastatic Disease to Facilitate Clinical Trial Patient Ascertainment. JCO Clin Cancer Inform. 2021 Jun;5:719-727. doi: 10.1200/CCI.20.00180. PMID: 34197178.
Copy Download .nbib Format: NLM
Showing 2761 to 2772 of 2788 entries